Observational Study of Iris Tumors
Recruiting
Observational Study
Iris Tumor
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Oregon Health and Science University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria for tumor group:
* Eyes with diagnosis of melanotic or amelanotic iris tumors
Inclusion Criteria for healthy control group:
* Eyes without iris defects or lesions
Exclusion Criteria (both groups):
* Inability to give informed consent
* Inability to maintain stable fixation fo…
Contacts